Search

everythinglearnresearchcommunity

for

Search:↓

Statins may help treat alopecia areata by reducing harmful immune interactions.

New hair regrowth model proposed, imiquimod found to kill skin cancer cells, T-cadherin loss linked to invasive skin cancer, no clear gene link to skin cancer after transplant, and study on children's hair loss shows male dominance and genetic ties.

Certain microRNAs may protect against hair loss in alopecia areata and could be potential treatment targets.

MicroRNAs are crucial for controlling skin development and healing by regulating genes.

Alopecia areata affects many in the US, impacting quality of life, with limited treatment options.

Razor bumps are linked to a genetic variant, misoprostol helps erythromelalgia pain, steroid ointments don't affect skin rhythms, and certain antibodies are common in localized scleroderma.

New medications could improve treatment for severe alopecia areata in Australia.

A substance called miR-1246 may help treat severe hair loss by reducing certain immune cell activities.

A man with nevus comedonicus syndrome had multiple skin issues, including basal cell carcinomas, which improved with treatment.

A rare type of skin cancer on the scalp can be mistaken for hair loss, causing delayed diagnosis and severe damage.

The document says that common skin conditions in adult women can be treated effectively, with acne being the most common and early-detected melanoma having a high survival rate.

A 5-year-old boy has Nevus Comedonicus Syndrome, causing skin lesions and a cataract.

Australian dermatologists are updating their prescriptions for male pattern baldness.

The PI's development is closely linked to skin and hair pigmentation in macaques.

Melatonin can affect skin color, treat skin conditions, and may help with skin cancer.

The supplement highlighted advancements and challenges in plastic and reconstructive surgery, including the impact of smoking, chemotherapy, and new treatments like Tafluprost for hair loss.

Patients with rapidly progressive alopecia areata often have a better outlook and shorter disease duration, with regrown fine hairs and no past alopecia being positive signs.

The meeting showcased rare skin disease cases, highlighting the need for accurate diagnosis and treatment.

The conference highlighted new dermatological treatments and emphasized early intervention and addressing conditions lacking evidence-based treatments.

Antigens from skin cells may cause hair loss in perinevoid alopecia.

Tofacitinib shows promise for treating severe alopecia areata with good safety and effectiveness.

Nerve fibers may worsen mast cell activity, leading to abnormal elastic fiber buildup from sun exposure.

Mirex seems to promote a unique group of skin cells different from those affected by another tumor promoter, TPA.

Patient-derived melanocytes can potentially treat vitiligo by restoring skin pigmentation.

Collagen VII helps skin heal and stay strong, sirolimus may lower skin cancer risk in kidney transplant patients, high-molecular-mass hyaluronan helps naked mole rats resist cancer, dermal γδ T cells aid in hair growth in rodents, and overexpression of IL-33 in mouse skin causes itchiness, offering a model for studying allergic inflammation treatments.

Sarcoidosis is more common and severe in Black patients than in Caucasians, requiring early diagnosis and treatment.

A man developed a painful skin condition after multiple heart procedures involving radiation.

Combining LFQS and IPL is more effective and faster for treating melasma than LFQS alone.

Mouse skin cancer progression involves a unique group of cells marked by ABCG2 and MTS24.